Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Rapid Dose Therapeutics Corp C.DOSE

Alternate Symbol(s):  RDTCF

Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream... see more

CSE:DOSE - Post Discussion

View:
Post by bajanjohn on Oct 28, 2023 7:59pm

Huge Increase

No one has said a word for over 4 months ( where is the quartely update) and now some shre price increase and still no one has said a word, this appears to be a "private" company with just share lenders (shareholders) that will one day wake up to a broke bankrupt company that sold off all their proprietary product , only to be bought by the same people. I am getting very concerned about the management and ther dealings and lack of transparency ......I guess they can always non-repot again for a year until they work out how to get all of our money.    COMMENTS?
Be the first to comment on this post